Showing Latest Articles
Comparison of Site-Reported and Core Laboratory-Reported Creatine Kinase-MB Values in Non–ST-Segment Elevation Acute Coronary Syndrome (from the International Trial SYNERGY)
The American Journal of Cardiology, 11/06/2009
Linefsky JP et al. – A substantial variation in CK–MB ratios and MI outcomes between the site and core laboratory data was observed in the SYNERGY trial. More MI outcomes were identified by the core laboratory, and patients with MI as defined by core laboratory data had lower 1–year survival, making these events potentially clinically important.
